| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.23 | 7e-06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |